Researchers developing rapid new detection systems for deadly blood infection

September 14, 2012
Researchers developing rapid new detection systems for deadly blood infection
Professor Cheng Hock-Toh: “Sepsis has a 30 to 50% mortality rate."

(Medical Xpress)—Scientists at the University of Liverpool are a step closer to providing clinicians with a bedside test for the early diagnosis of the fatal blood infection, sepsis. 

Sepsis is a bacterial infection of the blood that causes whole-body inflammation and is the leading cause of death worldwide.  Treating it in the early stages reduces the risk, but sepsis is difficult to diagnose until it has taken hold of the body.

Simple bedside test

Currently there are no reliable tests to accurately and speedily diagnose the infection, which can lead to delayed or missed diagnosis, resulting in complications or, in severe cases, death.  Researchers at Liverpool are developing new rapid detection systems that can analyse indicators of infection using a device at the bedside of a patient.

The team have already discovered a of the condition, which has proved to be a successful way of detecting the infection at its early stages in patients. The new £1.2 million project, supported by the Technology Strategy Board (TSB), is enabling scientists to work with Liverpool company, Sepsis Limited, to deliver a bedside test that is simple, rapid, and robust in detecting sepsis from a small sample of blood. 

Professor Cheng Hock-Toh, from the University's Institute of Infection and , said: " has a 30 to 50% mortality rate and recognising the infection in its earliest stages is crucial.  Now that we have validated the biomarkers of this condition we can focus on miniaturising test systems in the laboratory for point-of-care use at the bedside of patients." 

Also in development, through collaboration between the University, MicroLab Devices in Leeds, and Forsite Diagnostics in York, is a that can identify a combination of three indicators of from a sample of blood in less than five minutes.  Supported through funds from the TSB, it will allow to distinguish between serious blood infections and other more common bacterial infections in young children. 

Dr Enitan Carrol, from the University's Institute of Translational Medicine, said: "This new diagnostic device, which will combine two separate technologies, will reduce the delays in diagnosis and unnecessary admissions to hospitals, as well as the numbers of deaths from this serious condition.  We want to help doctors make the appropriate clinical decision at the bedside, without having to wait for results from a laboratory."

Explore further: Quicker detection and treatment of severe sepsis

Related Stories

Quicker detection and treatment of severe sepsis

May 23, 2011
Sepsis is the name of an infection that causes a series of reactions in the body, which in the worst case can prove fatal. The problem for both patients and doctors is that the early symptoms are difficult to distinguish ...

Researchers say urine dipstick test is accurate predictor of renal failure in sepsis patients

May 14, 2012
Henry Ford Hospital researchers have found that the presence of excess protein in a common urine test is an effective prognostic marker of acute renal failure in patients with severe sepsis.

Clinical trial to treat septic shock under way at UMC

June 1, 2011
The death rate can be as high as 60 percent for people with underlying medical problems, and some 250,000 Americans die of severe sepsis annually.

Recommended for you

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.